TY  - CHAP
M1  - Book, Section
TI  - Alveolar Hemorrhage Syndromes
A1  - Chesnutt, Asha N.
A1  - Chesnutt, Mark S.
A1  - Prendergast, Niall T.
A1  - Prendergast, Thomas J.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
Y1  - 2021
N1  - 
T2  - Current Medical Diagnosis & Treatment 2021
AB  - Diffuse  alveolar  hemorrhage  may  occur  in  a  variety  of  immune  and  nonimmune  disorders.  Alveolar  infiltrates  on  chest  radiograph,  dyspnea,  anemia,  hemoptysis,  and  occasionally  fever  are  characteristic.  Rapid  clearing  of  diffuse  lung  infiltrates  within  2  days  is  a  clue  to  the  diagnosis  of  diffuse  alveolar  hemorrhage  (eFigure  9–26).  Pulmonary  hemorrhage  can  be  associated  with  an  increased  single-breath  diffusing  capacity  for  carbon  monoxide  (DLCO).  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2022/01/29
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1175807983
ER  -